Clinical
RSSArticles
-
Doppler Echo Risk Stratification in Aortic Stenosis
The dimensionless index is an accurate indicator of aortic stenosis severity of clear prognostic value.
-
Valve Disease and Thromboembolic Risk
ABSTRACT & COMMENTARY: In non-valvular atrial fibrillation patients, left ventricular valve disease increased the risk of thromboembolic events.
-
FDA Actions
FDA fast-tracks approval of a new drug combination for treatment of heart failure; warns about medication errors for two drugs; approves first monoclonal anti-body as second-line treatment for high cholesterol; green lights oral medication for treatment of locally advanced basal cell carcinoma; and approves two new hepatitis C treatments.
-
New Research Weighs Benefits of Triple Therapy for Patients Who Have Undergone PCI
A new study suggests that more is perhaps not better.
-
ECG Review: What are the Clinical Implications of this Rhythm?
This tracing was obtained from a 69-year-old woman with a long-term history of palpitations. Her symptoms had been increasing over recent weeks, in association with “chest tightness” and dizziness. Her prior medical history was benign, and she was hemodynamically stable at the time this tracing was recorded. How would you interpret this rhythm strip? What are the clinical implications of this rhythm?
-
Clinical Briefs
A closer look at non-alcoholic fatty liver disease, lifting the ban on total dietary fat, and the risks of digoxin use in AF patients.
-
Cholic Acid Capsules (Cholbam ®)
The cholic acid capsule is the first FDA-approved treatment for rare bile acid synthesis disorders.
-
Inferior Vena Cava Filters and Recurrent Pulmonary Embolism
Placement of retrievable inferior vena cava filters in individuals with concurrent deep vein thrombosis does not reduce the risk of recurrent pulmonary embolism.
-
Long-term Weight Loss Rivals Medications and Ablation for AF Rhythm Control
The authors conclude long-term sustained weight loss was possible and was associated with a significant reduction in atrial fibrillation burden.
-
Provocative Cardiovascular Testing for Everyone with Chest Pain?
ABSTRACT & COMMENTARY: Pain or not, it's hard to take money out of the medical equation.